Left ventricular assist devices in the community

Bowles, C.
July 2000
Perfusion;Jul2000, Vol. 15 Issue 4, p373
Academic Journal
Deals with the use of implantable cardiac left ventricular assist devices (LVAD). Viability of LVAD; Benefits of LVAD to patients; Discharge policy developed in line with the safety of LVAD recipients.


Related Articles

  • Healing from the Heart: Dr. Mehmet Oz.  // Medical Update;Mar2002, Vol. 27 Issue 9, p5 

    Provides information on several therapies for patients with heart disease.

  • Guidelines program improved adherence among patients with diabetes, ACS. Costa, Samantha; Ellis, Brian; Foster, Melissa; Kalvaitis, Katie; Volansky, Rob // Endocrine Today;Dec2012, Vol. 10 Issue 12, p30 

    The article focuses on the study by Dr. Prakash C. Deedwania and his colleagues at the Veteran Affairs (VA) Central California Health Care System/University of California, San Francisco, which revealed that guideline-based therapy contributed to improvements in most performance measures in acute...

  • Ischemic Heart Disease.  // Current Medical Literature: Cardiology;2006, Vol. 25 Issue 1, p23 

    The article focuses on the outcome of a study that compared an early invasive strategy (EIS) and a selectively invasive strategy (SIS) in the management of acute coronary syndromes in patients receiving aggressive medical therapy. Several drugs were initially given to the study participants. The...

  • Patient perception of the effect of treatment with candesartan in heart failure. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. O'Meara, Eileen; Lewis, Eldrin; Granger, Chris; Dunlap, Mark E.; McKelvie, Robert S.; Probstfield, Jeffrey L.; Young, James B.; Michelson, Eric L.; Ostergren, Jan; Carlsson, Jonas; Olofsson, Bertil; McMurray, John; Yusuf, Salim; Swedberg, Karl; Pfeffer, Marc A. // European Journal of Heart Failure;Jun2005, Vol. 7 Issue 4, p650 

    Abstract: Aims: To evaluate the effect of the angiotensin receptor blocker candesartan on patients'' perception of symptoms, using the McMaster Overall treatment evaluation (OTE), in a broad spectrum of patients with chronic heart failure (CHF). Methods and results: Patients with symptomatic...

  • Cardiogenic shock shortly after initial success of cardiac resynchronization therapy. Kanhai, S.M.; Viergever, E.P.; Bax, J.J. // European Journal of Heart Failure;Jun2004, Vol. 6 Issue 4, p477 

    Cardiac resynchronisation therapy (CRT) has been shown to improve symptoms, exercise capacity and left ventricular function, as well as a reduction in morbidity/mortality in heart failure patients. Failures following initial success of this treatment are mostly related to lead dislodgement....

  • American College of Cardiology.  // BioWorld Today;4/1/2008, Vol. 19 Issue 63, p5 

    The article reports on the result of a study by CV Therapeutics Inc. which revealed that ranolazine significantly shortened the QT interval of patients with LQT3, a hereditary form of long QT syndrome caused by a genetic mutation in the late sodium channel resulting to heart rhythm problems....

  • Cardiac hydatid cyst: a comment/ Cardiac hydatid cyst case recovered with medical treatment. Wiwanitkit, Viroj; Tekin, Recep // Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi;Jun2012, Vol. 12 Issue 4, p368 

    Two letters to the editor are presented, one in response to the article "Cardiac hydatid cyst case recovered with medical treatment," by Tekin R. Kara A.F., Tekin R.C. and Cmen D. published in 2011 issue and other by the authors in response to their article "Cardiac hydatid cyst case...

  • Coronary angiography or medical therapy in ACS? Kirchner, Jeff; Russell, John J. // Patient Care;Nov2005, Vol. 39 Issue 11, p67 

    The article discusses research being done on the use of coronary angiography or conservative medical therapy in patients with acute coronary syndrome. It references a study by K. A. Fox et al published in the 2005 issue of "Lancet." The study found that outcomes from coronary angiography and...

  • Pseudohypoaldosteronism: Successful Treatment with Home Electrolyte Monitoring. Smith, Jacquelin K.; Kemp, Stephen F. // Clinical Pediatrics;Oct1991, Vol. 30 Issue 10, p600 

    Discusses home monitoring of serum electrolyte concentrations as a therapeutic option for pseudohypoaldosteronism. Condition of a patient with life-threatening cardiac arrhythmia, associated with marked hyperkalemia and hyponatremia; Information on pseudohypoaldosteronism; Therapy received by...

  • C reactive protein for risk stratification in acute coronary syndromes? Verdict: unproven. Kennon S; Timmis A D; Whitbourn R; Knight C; Kennon, S; Timmis, A D; Whitbourn, R; Knight, C // Heart;Nov2003, Vol. 89 Issue 11, p1288 

    Although C reactive protein is intimately involved with the pathogenic mechanisms that drive acute coronary syndromes, there is no evidence that it is helpful for identifying patient groups who might benefit from particular treatment strategies


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics